Scalper1 News
Teva Pharmaceutical Industries (TEVA) made a long-rumored bid for smaller generics rival Mylan (MYL) on Tuesday — 82 a share. Both stocks rose in pre-market trading. But over-the-counter products maker Perrigo (PRGO), which has an offer from Mylan, fell in early trading. Israeli-based Teva offered to buy Mylan for $40.1 billion, or 82 a share, in equal parts cash and stock. “The proposed combination of Teva and Mylan would create a leading company Scalper1 News
Scalper1 News